Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study. - Yadav V; Bourdette DN; Bowen JD; Lynch SG; Mattson D; Preiningerova J; Bever CT Jr; Simon J; Goldstein A; Burrows GG; Offner H; Ferro AJ; et al. (Autoimmune diseases, 2012)